The announcement follows recent moves by MusclePharm to build on the company’s core strengths as a sports nutrition brand
September 1, 2015
MusclePharm will be working to increase operating profit margins to 10% and earnings before interest, taxes, depreciation and amortization (EBITDA) margins to 15 percent by 2020.